Lee S H, Chen S A, Tai C T, Chiang C E, Wu T J, Cheng C C, Chiou C W, Ueng K C, Wang S P, Chiang B N, Chang M S
Department of Medicine, National Yang-Ming University School of Medicine, Taiwan, ROC.
Cardiology. 1996 Jan-Feb;87(1):33-41. doi: 10.1159/000177057.
Twenty-six patients (mean age 39 +/- 17 years) with idiopathic sustained ventricular tachycardia (VT) were included for study. The patients were divided into two groups: group I: 14 patients with VT originating from the right ventricular outflow tract (wide QRS tachycardia with complete left bundle branch block pattern), and group II: 12 patients with VT originating from the left ventricle (wide QRS tachycardia with complete right bundle branch block pattern). Most of the group I patients (11/14) needed isoproterenol to facilitate induction of VT, and were sensitive to both verapamil and adenosine. Eight patients had successful radio-frequency (RF) ablation and were free of VT without any antiarrhythmic drugs. In group II, sustained VT was induced by programmed ventricular stimulation in all the patients (only 3 patients needed isoproterenol for facilitation); verapamil could terminate all the VT but none of the patients responded to adenosine. Eight patients received RF ablation and 6 patients had successful ablation without recurrent tachycardia on a long-term basis. Different sensitivity to adenosine and isoproterenol between right and left ventricular idiopathic VT suggested different underlying mechanisms for both types of VT. The patients who did not receive catheter ablation still had attacks of VT despite antiarrhythmic drug treatment; however, none of these patients had sudden death since the first attack of VT (mean 95 +/- 51 months), suggesting a benign prognosis in idiopathic VT.
26例特发性持续性室性心动过速(VT)患者(平均年龄39±17岁)纳入研究。患者分为两组:第一组:14例起源于右心室流出道的室性心动过速患者(宽QRS心动过速伴完全性左束支传导阻滞图形),第二组:12例起源于左心室的室性心动过速患者(宽QRS心动过速伴完全性右束支传导阻滞图形)。第一组大多数患者(11/14)需要异丙肾上腺素来诱发室性心动过速,且对维拉帕米和腺苷均敏感。8例患者成功进行了射频(RF)消融,无需任何抗心律失常药物即可无室性心动过速发作。在第二组中,所有患者均通过程控心室刺激诱发出持续性室性心动过速(仅3例患者需要异丙肾上腺素辅助);维拉帕米可终止所有室性心动过速,但无一例患者对腺苷有反应。8例患者接受了射频消融,6例患者成功消融,长期无心动过速复发。右心室和左心室特发性室性心动过速对腺苷和异丙肾上腺素的敏感性不同,提示两种类型室性心动过速的潜在机制不同。未接受导管消融的患者尽管接受了抗心律失常药物治疗仍有室性心动过速发作;然而,自首次室性心动过速发作以来(平均95±51个月),这些患者均未发生猝死,提示特发性室性心动过速预后良好。